LINCOLN PHARMA
Breakout from a BULLISH PENNANT.
Positive Earnings Results.
Lincoln Pharma.
M.Cap ₹ 1,154 Cr PE 14.3
Item YOY Sep 2023
Sales ⇡ 11% 156
EBIDT ⇡ 8% 31.2
Net profit ⇡ 17% 27.6
EPS ⇡ 17% ₹ 13.80
Disclaimer:
For educational purpose only.
Please do your own research before taking any trades.
Happy Trading!
Breakout from a BULLISH PENNANT.
Positive Earnings Results.
Lincoln Pharma.
M.Cap ₹ 1,154 Cr PE 14.3
Item YOY Sep 2023
Sales ⇡ 11% 156
EBIDT ⇡ 8% 31.2
Net profit ⇡ 17% 27.6
EPS ⇡ 17% ₹ 13.80
Disclaimer:
For educational purpose only.
Please do your own research before taking any trades.
Happy Trading!
Comment:
LINCOLN PHARMA crossed 595.
